Neurological Biomarkers Market: Research Organizations & Others Segment Is Expected To Grow At The Fastest CAGR

 Neurological Biomarkers Industry Overview

The global neurological biomarkers market size was valued at USD 6.1 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 12.9% from 2020 to 2028. The market growth can be attributed to a rise in the prevalence of neurological diseases, such as migraines, dementia, Alzheimer’s disease, brain tumors, and epilepsy. In addition, technological advancements and the need for early diagnosis of neurological disorders are contributing to the market growth. According to the WHO, in 2016, epilepsy accounted for around 13 million disability-adjusted life years and more than 0.5% of the global burden of disease. Increasing cases of Alzheimer’s disease in older people are expected to fuel market growth.

For instance, according to the WHO, globally, approximately 50 million people have dementia and about 10 million new cases are reported every year. Furthermore, according to the Alzheimer’s Association, approximately 13.8 million people aged 65 years and above are estimated to suffer from Alzheimer’s dementia by 2050. It is estimated that about 5.8 million people in the U.S. aged 65 years and above were affected by Alzheimer’s dementia in 2020.

Gather more insights about the market drivers, restrains and growth of the Global Neurological Biomarkers market

Recent advancements in biomarkers, such as biomarker signatures are making neurological diseases more treatable. This has resulted in noninvasive testing, faster drug development, and early diagnosis. Furthermore, digital biomarkers provide various pharmaceutical companies with contextual and supplemental information to conclude clinical trial decisions. National Institute of Neurological Disorders and Stroke provides funding, such as development grants & cooperative agreements, for researchers conducting studies related to biomarker discovery, analytical validation, & clinical validation.

Thus, the presence of organizations offering funds at various stages of research is anticipated to drive market growth. For instance, the University of North Texas Health Science Center (HSC) was awarded around USD 45.5 million funds from the National Institutes of Health (NIH) to support research regarding health disparities in Alzheimer’s and brain aging. NIH is offering additional funds for biomarkers research for the ongoing Health and Aging Brain Among Latino Elders (HABLE) study.

The use of biomarkers is majorly limited to researchers for understanding the disease progression & pathology and pharmaceutical companies to develop therapeutics for neurodegenerative disorders by utilizing these tests for patient identification & assessment of drug tolerance in subjects. However, there are a few direct-to-consumer or commercial tests available in the market, such as APOE ε4, to predict the presence of a particular gene responsible for Alzheimer’s or related brain disease.

 

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

  • Clinical Microbiology Market - The global clinical microbiology market size was valued at USD 9.1 billion in 2016 and is expected to develop at a CAGR of 6.7% over the forecast period. Constantly rising incidence of infectious diseases is driving market growth.

 

  • Hepatitis Diagnostic Test Market - The global hepatitis diagnostic test market size was valued at USD 3.9 billion in 2016 and is expected to grow at a CAGR of 6.5% over the forecast period. Rising prevalence of hepatitis diagnostics is primarily driving the growth of the global market.

 

Neurological Biomarkers Market Segmentation

Grand View Research has segmented the global neurological biomarkers market on the basis of type, application, end-use, and region:

Neurological Biomarkers Type Outlook (Revenue, USD Million, 2017 - 2028)

  • Genomic
  • Proteomic
  • Metabolomic
  • Imaging
  • Others

 

Neurological Biomarkers Applications Outlook (Revenue, USD Million, 2017 - 2028)

  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Multiple Sclerosis
  • Autism Spectrum Disorder
  • Others

 

Neurological Biomarkers End-use Outlook (Revenue, USD Million, 2017 - 2028)

  • Hospital & Hospital Laboratories
  • Independent Clinical Diagnostic Centers
  • Research Organizations & Others

 

Neurological Biomarkers Regional Outlook (Revenue, USD Million, 2017 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Market Share Insights

  • August 2020: Johnson & Johnson Services, Inc. entered into an agreement with Enigma Biomedical Group for the evaluation of novel neuroimaging biomarkers-JNJ-64413739 and JNJ-64511070-to understand Alzheimer’s disease and other dementias.

 

Key Companies profiled:

Some prominent players in the global Neurological Biomarkers market include

  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Banyan Biomarkers, Inc.
  • Myriad Genetics, Inc.
  • DiaGenic ASA
  • Quanterix 

 

Order a free sample PDF of the Neurological Biomarkers Market Intelligence Study, published by Grand View Research.

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more